Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.

Despite considerable efficacy of arsenic trioxide (As2O3) in acute promyelocytic leukemia (APL) treatment, other non-APL leukemias, such as chronic myeloid leukemia (CML), are less sensitive to As2O3 treatment. However, the underlying mechanism is not well understood. Here we show that relative As2O...

Full description

Bibliographic Details
Main Authors: Li-Li Song, Yao-Yao Tu, Li Xia, Wei-Wei Wang, Wei Wei, Chun-Min Ma, Dong-Hua Wen, Hu Lei, Han-Zhang Xu, Ying-Li Wu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4130628?pdf=render